Dr Qiang Chen said: “Our vaccine offers improved safety and potentially lowers the production costs more than any other current alternative, and with equivalent effectiveness.” Their Zika vaccine targets a key protein which envelopes the outside of the virus. However, it will be a long way to use the vaccine on humans. A special requirement exists for the Zika vaccine: “the people who will need it most, pregnant women, have the most worries about their own health, and the health of the fetus.”
Dr Qiang Chen
Governments, academic laboratories, and pharmaceutical companies invested heavily in stopping the virus. Maybe this time the problem can be solved. Dr. Chen , a molecular biologist with more than a decade of experience, is a Professor at the School of Life Sciences and a faculty member at the Center for Immunotherapy, Vaccines and Virotherapy in the Biodesign Institute of Arizona State University. Flavivirus therapeutics and vaccine development and the modulation of antibody-dependent enhancement (ADE) of viral infections are part of their research focus.